<DOC>
	<DOCNO>NCT00549055</DOCNO>
	<brief_summary>To assess effectiveness Macugen treatment neovascular age-related macular degeneration measure evolution visual acuity . Treatment duration , frequency administration combination treatment also evaluate .</brief_summary>
	<brief_title>A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life .</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>Patients diagnose subfoveal neovascular ( wet ) agerelated macular degeneration Patients receive least 1 Macugen injection Treatment naive patient , patient receive conventional therapy Patients sign date informed consent . Patients participate another clinical study Macugen .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Macugen Age-related macular degeneration ( AMD ) Observational study</keyword>
</DOC>